Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs

Tae Young Park, Hyoung Chul Oh, Evan L. Fogel, Glen A. Lehman

Research output: Contribution to journalReview article

Abstract

Acute pancreatitis is the most common and feared adverse event associated with performance of endoscopic retrograde cholangiopancreatography (ERCP). Unremitting effort has been made for over 40 years to minimize the frequency and severity of this complication. Recently, the use of rectal non-steroidal anti-inflammatory drugs (NSAIDs) have opened a new era for its prevention. This review focuses on the role of NSAIDs in pancreatitis, the pharmacokinetics of these agents, and summarizes the results of clinical trials with rectal NSAIDs alone and combination regimens in the prevention of post-ERCP pancreatitis.

Original languageEnglish (US)
Pages (from-to)535-543
Number of pages9
JournalKorean Journal of Internal Medicine
Volume35
Issue number3
DOIs
StatePublished - May 2020

Keywords

  • Anti-inflammatory agents
  • Cholangiopancreatography
  • Endoscopic retrograde
  • Non-steroidal
  • Pancreatitis

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs'. Together they form a unique fingerprint.

  • Cite this